Vaccine News and Research

Latest Vaccine News and Research

This small Canadian drugmaker wants to make J&J vaccines for poor nations. It needs more than a patent waiver.

Biolyse Pharma Corp., which makes a cancer medication, was gearing up to start making generic biologic drugs, made from living organisms. Then the pandemic hit.

6 May 2021

Study finds link between pandemic-related income loss, financial strain and depression

Researchers have found an independent association between COVID-19-related income loss and financial strain and depression, according to the latest study from the COVID-19 Resilience Project, run by the Lifespan Brain Institute of Children's Hospital of Philadelphia and Penn Medicine.

6 May 2021

Transplant recipients with COVID-19 may show lower cellular and antibody immune responses

Transplant patients are typically on chronic immunosuppression, making them automatically more vulnerable to infection with SARS-CoV-2, the agent responsible for the loss of over three million lives in the current COVID-19 pandemic. A new study discusses evidence for subnormal immune responses following COVID-19 in this population.

6 May 2021

For Kurdish Americans in Nashville, a beloved leader’s death prompts vaccine push

On a sloppy spring day in mid-March, hundreds of Kurdish Americans gathered in a field outside Nashville, Tennessee, under a sea of black umbrellas. Some of the men carried a stretcher to an open grave, where a yellow backhoe waited.

6 May 2021

Salesforce, Google, Facebook. How big tech undermines California’s public health system.

California Gov. Gavin Newsom has embraced Silicon Valley tech companies and health care industry titans in response to the covid-19 pandemic like no other governor in America — routinely outsourcing life-or-death public health duties to his allies in the private sector.

6 May 2021

Researchers develop a multivalent vaccine for COVID-19 and influenza

Researchers at Duke University, USA, are looking into the possibility of a combined influenza and COVID-19 vaccine that could be used to simultaneously protect against annual flu strains and the SARS-CoV-2. Preclinical results showed the vaccine protected mice from both SARS-CoV-2 and the flu.

6 May 2021

Study: Millions of COVID-19 cases can be prevented by reaching higher vaccination coverage levels

With around 30 percent of the U.S. population now fully vaccinated, the rate of daily vaccinations has started to slow, raising concerns that greater efforts and investments may be needed to reach higher coverage levels.

6 May 2021

Benefits of drug research are not being shared equitably among study participants, indicates study

A Yale-led study reveals that new medicines and vaccines approved for use in the United States are often unavailable in countries that hosted their clinical trials, suggesting that the benefits of drug research are not being shared equitably among populations that participate in testing.

6 May 2021

WHO hails Sweden’s announcement to share 1 million doses of AstraZeneca vaccine with COVAX

WHO Dr Tedros Adhanom Ghebreyesus welcomed the Government of Sweden's announcement today to share 1 million doses of the AstraZeneca vaccine with the COVAX Facility to provide life-saving vaccines to people at risk from COVID-19 in low income countries.

6 May 2021

World Health Organization lists Moderna COVID-19 vaccine for emergency use

Today, WHO listed the Moderna COVID-19 vaccine (mRNA 1273) for emergency use, making it the fifth vaccine to receive emergency validation from WHO.

6 May 2021

Microneedles for cancer immunotherapy may lead to minimal invasiveness, side effects

A recent study from the University of Helsinki monitors the breakthrough progresses in the development of microneedles for immunotherapy and discusses the challenges regarding their production.

6 May 2021

Study: Second vaccine dose still makes organ transplant recipients vulnerable to COVID-19

In a study published today in the Journal of the American Medical Association (JAMA), Johns Hopkins Medicine researchers show that although two doses of a vaccine against SARS-CoV-2 - the virus that causes COVID 19 - confers some protection for people who have received solid organ transplants, it's still not enough to enable them to dispense with masks, physical distancing and other safety measures.

6 May 2021

New study documents possible adverse events in relation to Vaxzevria COVID-19 vaccine

The new Danish-Norwegian study is the first study to document possible adverse events in relation to the COVID-19 vaccine Vaxzevria from AstraZeneca, in which all vaccine recipients have been followed systematically, as opposed to previous studies, which have relied primarily on reported adverse reactions.

6 May 2021

Researchers identify potent small molecule TMPRSS2 inhibitor against SARS-CoV-2

A team of scientists from the USA and Canada has recently identified and characterized a novel small-molecule compound inhibitor of cellular serine protease TMPRSS2, which shows significant antiviral potency against emerging variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

5 May 2021

Novel pipeline identifies millions of molecular targets in SARS-CoV-2

Researchers in the United States have developed a novel pipeline for high-throughput, automated annotation of the genes, proteins and functional domains in the genome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

5 May 2021

Vaccine News and Research

Latest Vaccine News and Research

This small Canadian drugmaker wants to make J&J vaccines for poor nations. It needs more than a patent waiver.

Study finds link between pandemic-related income loss, financial strain and depression

Transplant recipients with COVID-19 may show lower cellular and antibody immune responses

For Kurdish Americans in Nashville, a beloved leader’s death prompts vaccine push

Salesforce, Google, Facebook. How big tech undermines California’s public health system.

Researchers develop a multivalent vaccine for COVID-19 and influenza

Study: Millions of COVID-19 cases can be prevented by reaching higher vaccination coverage levels

Benefits of drug research are not being shared equitably among study participants, indicates study

WHO hails Sweden’s announcement to share 1 million doses of AstraZeneca vaccine with COVAX

World Health Organization lists Moderna COVID-19 vaccine for emergency use

Microneedles for cancer immunotherapy may lead to minimal invasiveness, side effects

Study: Second vaccine dose still makes organ transplant recipients vulnerable to COVID-19

New study documents possible adverse events in relation to Vaxzevria COVID-19 vaccine

Researchers identify potent small molecule TMPRSS2 inhibitor against SARS-CoV-2

Novel pipeline identifies millions of molecular targets in SARS-CoV-2

Prior MMR or Tdap vaccination may reduce risk of severe COVID-19

New project aims to develop a digital health solution for promoting COVID-19 vaccination

Researchers reach new milestone in the development of effective malaria vaccine

Study: Only half of Americans with a history of heart disease get annual flu shot

Women’s views on COVID-19 vaccination during pregnancy: A UK-based study

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Vaccine News and Research

Latest Vaccine News and Research

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in